• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0302
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Aneurysm (1708); Fistula (1862); Hematoma (1884); Pain (1994); Stenosis (2263)
Event Date 11/14/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).The steerable guide catheter was discarded and there was no device malfunction reported.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report the access site aneurysm, fistula, hematoma, and stenosis.It was reported that this was a mitraclip procedure to treat grade 3 mixed etiology mitral regurgitation (mr).On (b)(6) 2018 one mitraclip was implanted through the steerable guide catheter via the right groin access site, reducing mr grade to 1.On (b)(6) 2018 the patient had right groin pain.Duplex sonography found an aneurysm spurium arterio-venous fistula, hematoma, and stenosis of the femoral artery.Compression and compression bandages were performed for 24 hours; medication was administered, but the condition persisted.Surgical intervention for the condition was performed on (b)(6) 2018.No additional information was provided.
 
Manufacturer Narrative
Internal file number: (b)(4).Two steerable guide catheters (sgc) were used.Since it could not be confirmed which of these may have contributed to the reported patient effects, the lot history record review is provided for both lots.The results are as follows: lot 80621u255: manufacturing date: 21-june-2018, expiration date: 21-june-2019.Lot 80815u108: manufacturing date: 15-august-2018, expiration date: 15-august-2019.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issues to the reported lot that would have contributed to this event.Review of the complaint history revealed no evidence of a lot-specific product quality issue.The reported patient effects of aneurysm, fistula, hematoma, pain, stenosis and surgery are listed in the mitraclip system instructions for use, as known possible complications associated with mitraclip procedures.The reported patient effects appear to be related to patient morphology/pathology and/or user technique/procedural conditions.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8158379
MDR Text Key130161072
Report Number2024168-2018-09631
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 01/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSGC0302
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/23/2018
Initial Date FDA Received12/12/2018
Supplement Dates Manufacturer Received01/24/2019
Supplement Dates FDA Received01/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CLIP DELIVERY SYSTEM
Patient Outcome(s) Required Intervention;
Patient Age76 YR
Patient Weight72
-
-